Design of Cancer Screening Trials/Randomized Trials for Evaluation of Cancer Screening

Miller, Anthony B.
July 2006
World Journal of Surgery;Jul2006, Vol. 30 Issue 7, p1152
Academic Journal
The article reports on the use of randomized screening trials(RST) in evaluating the effectiveness of screening for cancer. Several aspects of RST's design which were in used is discussed such as the appropriate time to conduct RST, study population selection, randomization and administration of screening.


Related Articles

  • Design arid Endpoints of Clinical Trials in Hepatocellular Carcinoma. Llovet, Josep M.; Di Bisceglie, Adrian M.; Bruix, Jordi; Kramer, Barnett S.; Lencioni, Riccardo; Zhu, Andrew X.; Sherman, Morris; Schwartz, Myron; Lotze, Michael; Taiwalkar, Jayant; Gores, Gregory J. // JNCI: Journal of the National Cancer Institute;5/21/2008, Vol. 100 Issue 10, p698 

    The design of clinical trials in hepatocellular carcinoma (HCC) is complex because many patients have concurrent liver disease, which can confound the assessment of clinical benefit. There is an urgent need for high-quality trials in this disease. An expert panel was convened by the American...

  • Targeted Cancer Therapies Lagging. Hampton, Tracy // JAMA: Journal of the American Medical Association;10/25/2006, Vol. 296 Issue 16, p1951 

    The article states that the U.S. Food and Drug Administration has created a new program called the Critical Path Initiative to improve the preclinical and clinical testing of drugs and medical devices used in the molecular diagnosis and treatment of cancer. The initiative will use biomarkers to...

  • Blinding in pharmacological trials: the devil is in the details. Wan, Mandy; Orlu-Gul, Mine; Legay, Helene; Tuleu, Catherine // Archives of Disease in Childhood;Sep2013, Vol. 98 Issue 9, p656 

    The article offers information on blinding methodologies of the information generated from randomized controlled trials (RCT). It informs the blinding is important for removing inadequacy can lead to trial delayed and increased costs. It informs that blinding of the data of the clinical trials...

  • A two-way enriched clinical trial design: combining advantages of placebo lead-in and randomized withdrawal. Ivanova, Anastasia; Tamura, Roy N. // Statistical Methods in Medical Research;Dec2015, Vol. 24 Issue 6, p871 

    A new clinical trial design, designated the two-way enriched design (TED), is introduced, which augments the standard randomized placebo-controlled trial with second-stage enrichment designs in placebo non-responders and drug responders. The trial is run in two stages. In the first stage,...

  • SIMULATION: A Critical Tool in Adaptive. Nicholls, Graham; Patel, Nitin; Byrom, Bill // Applied Clinical Trials;Jun2009, Vol. 18 Issue 6, p76 

    The article discusses the importance of simulation as a critical tool in planning and implementation of adaptive clinical trials. It states that simulation helps researchers in planning, understanding and investigating a complex system and in exploring study designs. It presents a case study on...

  • Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. Ferreira-González, I.; Busse, J. W.; Heels-Ansdell, D.; Montori, V. M.; Akl, E. A.; Bryant, D. M.; Alonso, J.; Jawschke, R.; Schünemann, H. J.; Permanyer-Miralda, G.; Domingo-Salvany, A.; Guyatt, G. h. // BMJ: British Medical Journal (International Edition);4/14/2007, Vol. 334 Issue 7597, p786 

    Objective To explore the extent to which components of composite end points in randomised controlled trials vary in importance to patients, the frequency of events in the more and less important components, and the extent of variability in the relative risk reductions across components. Design...

  • Clinical studies on posterior cruciate ligament tears have weak design. Watsend, Anne; Osestad, Toril; Jacobsen, Rune; Engebretsen, Lars // Knee Surgery, Sports Traumatology, Arthroscopy;Feb2009, Vol. 17 Issue 2, p140 

    Very few studies in the literature focus on isolated PCL injury. Recent studies are in general more optimistic with regard to the results than previous reports. There are few randomized controlled trials and few prospective comparative studies, which may limit the value of the reported results....

  • Reports of Substance Abuse Prevention Programming Available in Schools. Sloboda, Zili; Pyakuryal, Amod; Stephens, Peggy C.; Teasdale, Brent; Forrest, David; Stephens, Richard C.; Grey, Scott F. // Prevention Science;Dec2008, Vol. 9 Issue 4, p276 

    Evaluations of school-based substance abuse prevention programs with schools or school districts randomly assigned to either the treatment or control condition have demonstrated effective strategies over the past 30 years. Although control schools were never considered “pure” (i.e.,...

  • Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3μg/g in Patients with Mild-to-moderate Plaque Psoriasis. Lebwohl, Mark; Preston, Norman; Gottschalk, Ronald W. // Journal of Clinical & Aesthetic Dermatology;Feb2012, Vol. 5 Issue 2, p28 

    Objective: Calcitriol 3μg/g ointment has been shown to be a safe and effective treatment for adults with mild-tomoderate plaque psoriasis. This analysis evaluated the response to calcitriol 3μg/g ointment relative to baseline disease. Design: Retrospective analysis of data from a 12-month...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics